You are reading Entrepreneur India, an international franchise of Entrepreneur Media.
Global investment firm KKR has acquired Healthium Medtech Ltd. (“Healthium”), an Indian medical device company, in a fund advised by Apax Partners LLP (“Apax”), a global private equity advisory firm. announced the conclusion of a final agreement to acquire the company from an affiliated company. .
A fund managed by KKR will acquire a controlling interest in the Healthiam Group, which includes Healthiam, through a special purpose vehicle.
The transaction is expected to close in the third quarter of 2024, subject to certain regulatory approvals. Financial information was kept private.
Akshay Tanna, Partner and Head of India Private Equity at KKR, said, “We will leverage our global network and healthcare expertise to accelerate growth in this fast-growing sector and develop organic and inorganic growth strategies. We look forward to further expanding our global business through this initiative.” ”
Founded in 1992, Healthium is a medical device company that develops, manufactures and markets a wide range of surgical products worldwide. Its portfolio serves a wide range of surgeons' needs, offering wound closure, arthroscopy, and advanced wound closure products.
Anish Bafna, CEO of Healthium, said: “Over the past five years, Apax's support and partnership has significantly accelerated Healthium's growth. Our products are now sold in 1 in 5 products worldwide. The market in which we are present has almost doubled.”
Global equity finance firm Apax Partners LLP acquired Healthium in 2018 and strengthened its leadership with the hiring of Vishal Maheshwari as CFO and Anish Bafna as CEO.
“Thanks to our years of experience working with medical device companies, we saw an opportunity to leverage Healthium's strong existing portfolio to build a globally diversified MedTech platform,” said Steven Dyson, partner at Apax. ” he said.
Jefferies LLC provided financial advice to Apax Partners and Healthium, and Kirkland & Ellis LLP provided legal advice. Moelis & Company provided financial advice to KKR, and Simpson Thacher & Bartlett and AZB & Partners provided legal advice.
KKR invests through Asia Fund IV.
Top pharma companies in the region include JB, Max Healthcare, Gland Pharma, PHC, Bushu Pharma and Metro Pacific Hospitals, just a few of the companies that have received investments from Asia Fund IV in India and Asia Pacific. It's just that.
